Loading
Total declarations
Company
▲ Purchases (4 ops.)
▼ Sales (0 ops.)
Latest filing published 24 Jul 2026 for Angiodynamics INC. Read the official filing
Filing timeline
BuySaleStephen A. Trowbridge
Insider track record
Disclosed buys
4
Disclosed sells
0
T+90 hit rate
25%
T+90 mean return
+11.4%
Across 4 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Stephen A. Trowbridge: trading record in brief
All filings by Stephen A. Trowbridge on record concern Angiodynamics Inc, in the capacity of finance chief. Between 14 July 2021 and 22 July 2026, the trades on record add up to 34 filings.
Every open-market trade on record is a purchase: 4 purchases worth €53k, and no sale. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. The rest of the record consists of 22 share grants and 8 option exercises.
The median purchase comes to €12k. Of 4 purchases, 4 formed part of a group of insiders buying within 30 days of each other. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase.
Most recently, on 24 July 2026, the filings show an option exercise in Angiodynamics Inc. The most recent open-market purchase was published on 14 October 2025, 369 days ago. Filings reach the SEC (Form 4) feed a median of 4 days after the trade. US insiders must file a Form 4 within two business days of a trade. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Stephen A. Trowbridge
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations34 total
16,296 shares0Common StockSEC:0001140361-26-029634:0
8,319 shares@ US$13.820.021% mcap15.3% of flowCommon StockSEC:0001140361-26-029634:1
53,257 shares0Common StockSEC:0001140361-26-029334:0
3,510 shares@ US$13.510.0085% mcap7.4% of flowCommon StockSEC:0001140361-26-029188:1
7,840 shares@ US$14.140.020% mcap17.4% of flowCommon StockSEC:0001140361-26-029188:0
717 shares@ US$13.710.0018% mcap1.5% of flowCommon StockSEC:0001140361-26-029188:2
890 shares@ US$11.161.8% of flowCommon StockSEC:0001140361-25-038018:0
Canonical exit: 11 Jan 2026 (T+90)
2,585 shares@ US$8.694.1% of flowCommon StockSEC:0001140361-25-026800:0
717 shares@ US$8.691.1% of flowCommon StockSEC:0001140361-25-026800:1
667 shares@ US$8.991.1% of flowCommon StockSEC:0001140361-25-026800:2
86,997 shares0Common StockSEC:0001140361-25-026462:0
1,700 shares@ US$5.861.9% of flowCommon StockSEC:0001140361-24-043173:0
Canonical exit: 6 Jan 2025 (T+90)
11,142 shares0Common StockSEC:0001140361-24-035597:0
717 shares@ US$7.131.0% of flowCommon StockSEC:0001140361-24-034268:0
38,953 shares0Common StockSEC:0001140361-24-033629:0
1,927 shares@ US$4.671.7% of flowCommon StockSEC:0001140361-24-011190:0
19,354 shares0Common StockSEC:0001140361-23-044840:0
8,769 shares0Common StockSEC:0001140361-23-036318:0
717 shares@ US$8.741.2% of flowCommon StockSEC:0001140361-23-036121:0
667 shares@ US$8.651.1% of flowCommon StockSEC:0001140361-23-036121:1
28,691 shares0Common StockSEC:0001140361-23-035726:0
1,362 shares@ US$9.632.4% of flowCommon StockSEC:0001140361-23-035087:0
376 shares@ US$9.560.7% of flowCommon StockSEC:0001140361-23-035087:1
555 shares@ US$13.431.4% of flowCommon StockSEC:0001567619-23-002005:0
1,083 shares@ US$13.823.2% of flowCommon StockSEC:0001567619-22-018449:0
Canonical exit: 10 Jan 2023 (T+90)
25 of 34 declarations
